FDA Issues Complete Response Letter To VIVUS Regarding New Drug Application For QNEXA®
October 31st, 2010 by admin
VIVUS, Inc. (Nasdaq: VVUS) announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form… [...]
Tags: 3m Company, Arena Pharmaceuticals, Crl, Drug Application, Drug Phentermine, Fda, Fda Issues, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Goog, Google, Google Inc, Hep C, Ir Firm, Magnetic Gate, Market Movers, Nasdaq, Nda, Oplk, phentermine, Pwer, Qnexa, Release Capsules, Response Letter, Tech24, Tnav, Vivus Inc, Vvus, WikileaksPosted in
